Pampaloni MH - Search Results

1

Increased FDG avidity in lymphoid tissue associated with response to combined immune checkpoint blockade.

Tsai KK, Pampaloni MH, Hope C, Algazi AP, Ljung BM, Pincus L, Daud AI. Tsai KK, et al. Among authors: pampaloni mh. J Immunother Cancer. 2016 Sep 20;4:58. doi: 10.1186/s40425-016-0162-9. eCollection 2016. J Immunother Cancer. 2016. PMID: 27660712 Free PMC article.

2

The combination of axitinib followed by paclitaxel/carboplatin yields extended survival in advanced BRAF wild-type melanoma: results of a clinical/correlative prospective phase II clinical trial.

Algazi AP, Cha E, Ortiz-Urda SM, McCalmont T, Bastian BC, Hwang J, Pampaloni MH, Behr S, Chong K, Cortez B, Quiroz A, Coakley F, Liu S, Daud AI. Algazi AP, et al. Among authors: pampaloni mh. Br J Cancer. 2015 Apr 14;112(8):1326-31. doi: 10.1038/bjc.2014.541. Epub 2015 Mar 31. Br J Cancer. 2015. PMID: 25867272 Free PMC article. Clinical Trial.

3

Tumor immune profiling predicts response to anti-PD-1 therapy in human melanoma.

Daud AI, Loo K, Pauli ML, Sanchez-Rodriguez R, Sandoval PM, Taravati K, Tsai K, Nosrati A, Nardo L, Alvarado MD, Algazi AP, Pampaloni MH, Lobach IV, Hwang J, Pierce RH, Gratz IK, Krummel MF, Rosenblum MD. Daud AI, et al. Among authors: pampaloni mh. J Clin Invest. 2016 Sep 1;126(9):3447-52. doi: 10.1172/JCI87324. Epub 2016 Aug 15. J Clin Invest. 2016. PMID: 27525433 Free PMC article.

4

Partially exhausted tumor-infiltrating lymphocytes predict response to combination immunotherapy.

Loo K, Tsai KK, Mahuron K, Liu J, Pauli ML, Sandoval PM, Nosrati A, Lee J, Chen L, Hwang J, Levine LS, Krummel MF, Algazi AP, Pampaloni M, Alvarado MD, Rosenblum MD, Daud AI. Loo K, et al. JCI Insight. 2017 Jul 20;2(14):e93433. doi: 10.1172/jci.insight.93433. eCollection 2017 Jul 20. JCI Insight. 2017. PMID: 28724802 Free PMC article.

5

The incidence of pulmonary embolism and associated FDG-PET findings in IV contrast-enhanced PET/CT.

Flavell RR, Behr SC, Brunsing RL, Naeger DM, Pampaloni MH. Flavell RR, et al. Among authors: pampaloni mh. Acad Radiol. 2014 Jun;21(6):718-25. doi: 10.1016/j.acra.2014.02.013. Acad Radiol. 2014. PMID: 24809314 Free article.

6

Abnormal 18F-FDG and 82Rb PET Findings in Chagas Heart Disease.

Salimy MS, Parwani PJ, Mukai K, Pampaloni MH, Flavell RR. Salimy MS, et al. Among authors: pampaloni mh. Clin Nucl Med. 2017 May;42(5):e265-e268. doi: 10.1097/RLU.0000000000001622. Clin Nucl Med. 2017. PMID: 28263213 Free article.

7

Prevalence and Characteristics of Incidentalomas Discovered by Whole Body FDG PETCT.

Pampaloni MH, Win AZ. Pampaloni MH, et al. Int J Mol Imaging. 2012;2012:476763. doi: 10.1155/2012/476763. Epub 2012 Mar 18. Int J Mol Imaging. 2012. PMID: 22523679 Free PMC article.

8

Frequency and clinical implications of incidental new primary cancers detected on true whole-body 18F-FDG PET/CT studies.

Sebro R, Aparici CM, Pampaloni MH. Sebro R, et al. Among authors: pampaloni mh. Nucl Med Commun. 2013 Apr;34(4):333-9. doi: 10.1097/MNM.0b013e32835f163f. Nucl Med Commun. 2013. PMID: 23407371

9

PET/MRI radiotracer beyond ¹⁸F-FDG.

Pampaloni MH, Nardo L. Pampaloni MH, et al. PET Clin. 2014 Jul;9(3):345-9. doi: 10.1016/j.cpet.2014.03.010. PET Clin. 2014. PMID: 25030398 Review.

10

Initial experience of dedicated breast PET imaging of ER+ breast cancers using [F-18]fluoroestradiol.

Jones EF, Ray KM, Li W, Chien AJ, Mukhtar RA, Esserman LJ, Franc BL, Seo Y, Pampaloni MH, Joe BN, Hylton NM. Jones EF, et al. Among authors: pampaloni mh. NPJ Breast Cancer. 2019 Apr 16;5:12. doi: 10.1038/s41523-019-0107-9. eCollection 2019. NPJ Breast Cancer. 2019. PMID: 31016232 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters